What Is Scleroderma?

Types of Scleroderma
Localized Scleroderma
- Morphea involves patches of localized scleroderma a half-inch or more in diameter.
- Linear scleroderma is thickening and forms a line, which usually extends down a limb but can also run down the face.
Systemic Scleroderma
- Limited cutaneous scleroderma affects the skin slowly over time. It’s typically confined to your fingers, hands, lower arms and legs, usually below the knees.
- Diffuse cutaneous scleroderma takes effect quickly. It may begin with your fingers and toes before spreading across your arms, legs, and torso and can affect multiple organs, including the gastrointestinal tract, kidneys, lungs, and heart.
Signs and Symptoms of Scleroderma
Localized Scleroderma Symptoms
- Patches of thick, hardened, oval-shaped skin, possibly with a yellow, waxy appearance with an edge resembling a bruise (morphea)
- Thickened or discolored skin that forms a line running down an arm, leg, and, rarely, forehead

Systemic Scleroderma Symptoms
- Red spots (called telangiectasia)
- Calcium deposits under the skin, especially the fingertips
- Raynaud’s phenomenon, which causes pain or numbness in your fingers and toes as a result of contraction of the small blood vessels
- Bloating
- Diarrhea
- Incontinence
- Constipation
- Heartburn
- Difficulty swallowing
- Shortness of breath
- Dizziness
- Fatigue
- Pulmonary hypertension
- Heart failure
- Organ damage
- Joint pain
Causes and Risk Factors of Scleroderma
Scleroderma’s development is complex and not entirely understood, but dysregulation of the immune system, vascular damage, and excessive deposition of fibrosis and collagen in tissue are thought to play a part. Relatedly, the root cause of scleroderma is unknown, as with many autoimmune disorders, but researchers have identified several possible contributing factors.
- Genetics There is no single gene for scleroderma, but your genes influence your odds of developing it, the disease’s patterns, and what antibodies associated with the disease are present. People who have a first-degree relative (a parent or sibling) with scleroderma are at higher risk than other people.
- Environment Certain chemicals or environmental factors may trigger scleroderma, including silica and organic solvents.
- Gender As many as 80 percent of people diagnosed with scleroderma are women. This may be due to hormonal or immunological differences between the sexes.
- Race People of European descent are more susceptible to localized forms of scleroderma than African Americans, while African Americans and Choctaw Native Americans are at greater risk for systemic scleroderma.
- Age People between ages 30 and 50 are most susceptible to scleroderma.
How Is Scleroderma Diagnosed?
Tests for organ involvement in systemic scleroderma may include:
- Computerized tomography
- An echocardiogram
- Pulmonary function tests
- A chest X-ray
- An endoscopy
- Your primary care physician will also refer you to a rheumatologist for further examination.
Treatment and Medication Options for Scleroderma
Scleroderma has no cure, but the right interventions can help keep your symptoms in check and improve your quality of life.
Medications
- Anti-inflammatory medications
- Topical creams or lotions
- Immunosuppressants
- Vasodilators, for widening blood vessels
Surgery
Complementary and Integrative Therapies
- Physical therapy
- Light therapy, which uses bright, focused ultraviolet light to treat thickened skin
Lifestyle Changes for Scleroderma
- Stay warm by dressing in layers and wearing gloves and socks.
- Avoid cold or wet environments that might trigger the symptoms of Raynaud’s phenomenon.
- Avoid smoking, which causes blood vessels to contract and can worsen your symptoms.
- Use a humidifier if you’re in a colder climate.
- Avoid bathing with hot water, which dries out the ski.
- Get regular exercise, but don’t overdo it. Swimming is particularly beneficial for stimulating blood circulation.
- See a therapist for help coping with your illness.
- Visit the dentist regularly to manage effects of the thickening of mouth and facial tissue.
- For digestive symptoms, eat small, frequent meals, stay hydrated, and reduce or eliminate your intake of alcohol and caffeine.
- Consider using a wedge pillow or raising the head of your bed with blocks to help.
Scleroderma Prognosis
Complications of Scleroderma
According to Cleveland Clinic, people with scleroderma have a much higher likelihood than the general population to have two conditions: Raynaud’s phenomenon and Sjögren’s syndrome.
Systemic scleroderma can cause a wide range of complications since it can afflict so many parts of the body. Possible complications of systemic forms of scleroderma include:
- Scarring of heart or lung tissue
- Cardiovascular issues
- Inflammation of the sac surrounding the heart
- A weakened immune system
- Gastrointestinal diseases
- Difficulty brushing or cleaning teeth (due to tightening of the facial skin)
Research and Statistics: Who Has Scleroderma?
Scleroderma is rare. An estimated 300,000 Americans have the condition, and within that population, about 100,000 have systemic scleroderma. It’s possible that many people have undiagnosed or misdiagnosed scleroderma given the difficulty of diagnosis.
Disparities in Scleroderma
Support for Scleroderma
The Takeaway
- Scleroderma is an autoimmune condition characterized by impaired regulation and deposition of collagen, which causes inflammation and fibrosis throughout the body, including skin, blood vessels, internal organs, and the digestive tract.
- Scleroderma can affect anyone of any age, but it is most common in women and adults between 25 and 55.
- There is no cure for scleroderma, but the right treatments and lifestyle can alleviate your symptoms and minimize their impact on your daily life.
Common Questions & Answers
Resources We Trust
- Mayo Clinic: Scleroderma
- Cleveland Clinic: Scleroderma
- National Institute of Arthritis and Musculoskeletal and Skin Diseases: Scleroderma: Diagnosis, Treatment, and Steps to Take
- National Scleroderma Foundation: National Scleroderma Foundation
- American College of Rheumatology: Scleroderma
- Scleroderma. Mayo Clinic. June 15, 2024.
- Scleroderma. National Institute of Arthritis and Musculoskeletal and Skin Diseases. September 2023.
- Scleroderma. Cleveland Clinic. September 29, 2023.
- Ouchene L et al. Toward Understanding of Environmental Risk Factors in Systemic Sclerosis. Journal of Cutaneous Medicine and Surgery. September 28, 2020.
- Scleroderma Risk Factors. Johns Hopkins Medicine.
- Scleroderma: Diagnosis, Treatment, and Steps to Take. National Institute of Arthritis and Musculoskeletal and Skin Diseases. September 2023.
- Moghaddam MZ et al. Stem cell-based therapy for systemic sclerosis. Rheumatology Advances in Practice. November 20, 2023.
- Scleroderma Treatment. Johns Hopkins Medicine.
- Who Gets Scleroderma? National Scleroderma Foundation.
- Find Your Local Chapter. National Scleroderma Foundation.
- Scleroderma Support Groups. National Scleroderma Foundation.

Beth Biggee, MD
Medical Reviewer
Beth Biggee, MD, is medical director and an integrative rheumatologist at Rheumission, a virtual integrative rheumatology practice for people residing in California and Pennsylvania. This first-of-its-kind company offers whole person autoimmune care by a team of integrative rheumatologists, lifestyle medicine practitioners, autoimmune dietitians, psychologists, and care coordinators.
Dr. Biggee also works as a healthcare wellness consultant for Synergy Wellness Center in Hudson, Massachusetts. Teamed with Synergy, she provides in-person lifestyle medicine and holistic consults, and contributes to employee workplace wellness programs. She has over 20 years of experience in rheumatology and holds board certifications in rheumatology and integrative and lifestyle medicine. Dr. Biggee brings a human-centered approach to wellness rather than focusing solely on diseases.
Dr. Biggee graduated cum laude with a bachelor's degree from Canisius College, and graduated magna cum laude and as valedictorian from SUNY Health Science Center at Syracuse Medical School. She completed her internship and residency in internal medicine at Yale New Haven Hospital, completed her fellowship in rheumatology at Tufts–New England Medical Center, and completed training in integrative rheumatology at the University of Arizona Andrew Weil Center for Integrative Medicine. Following her training, she attained board certification in rheumatology and internal medicine through the American Board of Internal Medicine, attained board certification in integrative medicine through the American Board of Physician Specialties, and attained accreditation as a certified lifestyle medicine physician through the American College of Lifestyle Medicine. She is certified in Helms auricular acupuncture and is currently completing coursework for the Aloha Ayurveda integrative medicine course for physicians.
In prior roles, Dr. Biggee taught as an assistant clinical professor of medicine at Mary Imogene Bassett Hospital (an affiliate of Columbia University). She was also clinical associate of medicine at Tufts University School of Medicine and instructed "introduction to clinical medicine" for medical students at Tufts. She was preceptor for the Lawrence General Hospital Family Medicine Residency.
Dr. Biggee has published in Annals of Rheumatic Diseases, Arthritis in Rheumatism, Current Opinions in Rheumatology, Journal for Musculoskeletal Medicine, Medicine and Health Rhode Island, and Field Guide to Internal Medicine.
